{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:53:27Z","timestamp":1794020007804,"version":"4.8.0"},"reference-count":234,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.bcp.2023.115861","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T11:58:08Z","timestamp":1697630288000},"page":"115861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["NLRP3 inflammasome in hepatic diseases: A pharmacological target"],"prefix":"10.1016","volume":"217","author":[{"given":"Erika","family":"Ramos-Tovar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2236-6631","authenticated-orcid":false,"given":"Pablo","family":"Muriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2023.115861_b0005","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1016\/j.bcp.2023.115861_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4254\/wjh.v10.i1.1","article-title":"Role of inflammatory response in liver diseases: Therapeutic strategies","volume":"10","author":"Del Campo","year":"2018","journal-title":"World Journal of Hepatology"},{"issue":"2","key":"10.1016\/j.bcp.2023.115861_b0015","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3748\/wjg.v26.i2.109","article-title":"Inflammation and fibrosis in chronic liver diseases including nonalcoholic fatty liver disease and hepatitis C","volume":"26","author":"Tanwar","year":"2020","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.bcp.2023.115861_b0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.coi.2019.05.001","article-title":"Host inflammasome defense mechanisms and bacterial pathogen evasion strategies","volume":"60","author":"Brewer","year":"2019","journal-title":"Current Opinion in Immunology"},{"issue":"2","key":"10.1016\/j.bcp.2023.115861_b0025","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4049\/jimmunol.0901363","article-title":"Cutting Edge: NF-\u03baB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression","volume":"183","author":"Bauernfeind","year":"2009","journal-title":"Journal of Immunology"},{"issue":"1","key":"10.1016\/j.bcp.2023.115861_b0030","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-pathmechdis-032521-102529","article-title":"Role of the Inflammasome in Liver Disease","volume":"17","author":"de Carvalho Ribeiro","year":"2022","journal-title":"Annual Review of Pathology: Mechanisms of Disease"},{"issue":"9","key":"10.1016\/j.bcp.2023.115861_b0035","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/sj.cdd.4402194","article-title":"The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation","volume":"14","author":"Fernandes-Alnemri","year":"2007","journal-title":"Cell Death and Differentiation"},{"issue":"6","key":"10.1016\/j.bcp.2023.115861_b0040","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.cell.2014.02.008","article-title":"Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes","volume":"156","author":"Lu","year":"2014","journal-title":"Cell"},{"issue":"7081","key":"10.1016\/j.bcp.2023.115861_b0045","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nature04515","article-title":"Cryopyrin activates the inflammasome in response to toxins and ATP","volume":"440","author":"Mariathasan","year":"2006","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bcp.2023.115861_b0050","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/eji.201142079","article-title":"Sphingosine regulates the NLRP3-inflammasome and IL-1\u03b2 release from macrophages","volume":"42","author":"Luheshi","year":"2012","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.bcp.2023.115861_b0055","doi-asserted-by":"crossref","unstructured":"C.J. Gro\u00df, R. Mishra, K.S. Schneider, G. M\u00e9dard, J. Wettmarshausen, D.C. Dittlein, H. Shi, O. Gorka, P-A. Koenig, S. Fromm, G. Magnani, T. \u0106ikovi\u0107, L. Hartjes, J. Smollich, A.A.B. Robertson, M.A. Cooper, M. Schmidt-Supprian, M. Schuster, K. Schroder, Petr. Broz, C. Traidl-Hoffmann, B. Beutler, B. Kuster, J. Ruland, S. Schneider, F. Perocchi, Gro\u00df, K+ Efflux-Independent NLRP3 Inflammasome Activation by Small Molecules Targeting Mitochondria, Immunity. 45 (4) (2016) 761-773.","DOI":"10.1016\/j.immuni.2016.08.010"},{"issue":"3","key":"10.1016\/j.bcp.2023.115861_b0060","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.immuni.2012.06.013","article-title":"Cell volume regulation modulates NLRP3 inflammasome activation","volume":"37","author":"Compan","year":"2012","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.bcp.2023.115861_b0065","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3390\/antiox9121279","article-title":"Molecular Mechanisms That Link Oxidative Stress, Inflammation, and Fibrosis in the Liver","volume":"9","author":"Ramos-Tovar","year":"2020","journal-title":"Antioxidants."},{"issue":"7","key":"10.1016\/j.bcp.2023.115861_b0070","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nature Reviews. Immunology"},{"issue":"23","key":"10.1016\/j.bcp.2023.115861_b0075","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1242\/jcs.207365","article-title":"Inflammasome activation and assembly at a glance","volume":"130","author":"Malik","year":"2017","journal-title":"Journal of Cell Science"},{"issue":"1","key":"10.1016\/j.bcp.2023.115861_b0080","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","article-title":"Alcoholic liver disease","volume":"4","author":"Seitz","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"5","key":"10.1016\/j.bcp.2023.115861_b0085","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/cld.806","article-title":"Epidemiology of Alcohol Use and Alcoholic Liver Disease","volume":"13","author":"Mellinger","year":"2019","journal-title":"Clinics in Liver Disease"},{"issue":"04","key":"10.1016\/j.bcp.2023.115861_b0090","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1055\/s-0037-1608788","article-title":"Clinical Trial Design for Alcoholic Hepatitis","volume":"37","author":"Szabo","year":"2017","journal-title":"Seminars in Liver Disease"},{"issue":"3","key":"10.1016\/j.bcp.2023.115861_b0095","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/liv.12575","article-title":"Alcohol withdrawal alleviates adipose tissue inflammation in patients with alcoholic liver disease","volume":"35","author":"Voican","year":"2015","journal-title":"Liver International"},{"issue":"16","key":"10.1016\/j.bcp.2023.115861_b0100","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/0024-3205(86)90554-0","article-title":"Serum interleukin-1 (IL-1) activity in alcoholic hepatitis","volume":"39","author":"McClain","year":"1986","journal-title":"Life Sci"},{"key":"10.1016\/j.bcp.2023.115861_b0105","doi-asserted-by":"crossref","unstructured":"J. Petrasek, S. Bala, T. Csak, D. Lippai, K. Kodys, V. Menashy, M. Barrieau, S-Y, M, E.A. Kurt-Jones, G. Szabo, IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice, J. Clin. Invest. 122 (10) (2012) 3476-3489.","DOI":"10.1172\/JCI60777"},{"issue":"2","key":"10.1016\/j.bcp.2023.115861_b0110","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1189\/jlb.3AB1214-590R","article-title":"Metabolic danger signals, uric acid and ATP, mediate inflammatory crosstalk between hepatocytes and immune cells in alcoholic liver disease","volume":"98","author":"Petrasek","year":"2015","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/j.bcp.2023.115861_b0115","doi-asserted-by":"crossref","unstructured":"K. Cui, G. Yan, C. Xu, Y. Chen, Jun. Wang, R. Zhou, L. Bai, Z. Lian, H. Wei, R. Sun, Z. Tian, Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1\u03b2 in mice, J. Hepatol. 62 (6) (2015) 1311-1318.","DOI":"10.1016\/j.jhep.2014.12.027"},{"issue":"5","key":"10.1016\/j.bcp.2023.115861_b0120","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jhep.2015.06.013","article-title":"Inhibition of sterile danger signals, uric acid and ATP, prevents inflammasome activation and protects from alcoholic steatohepatitis in mice","volume":"63","author":"Iracheta-Vellve","year":"2015","journal-title":"Journal of Hepatology"},{"issue":"15","key":"10.1016\/j.bcp.2023.115861_b0125","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.3390\/nu15153346","article-title":"Effect of Alcohol Consumption Habits on Early Arterial Aging in Subjects with Metabolic Syndrome and Elevated Serum Uric Acid","volume":"15","author":"\u010cypien\u0117","year":"2023","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.bcp.2023.115861_b0130","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/gutjnl-2017-315123","article-title":"Alcohol dysregulates miR-148a in hepatocytes through FoxO1, facilitating pyroptosis via TXNIP overexpression","volume":"68","author":"Heo","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.bcp.2023.115861_b0135","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.redox.2017.04.020","article-title":"Mitochondrial ROS induced by chronic ethanol exposure promote hyper-activation of the NLRP3 inflammasome","volume":"12","author":"Hoyt","year":"2017","journal-title":"Redox Biology"},{"issue":"4","key":"10.1016\/j.bcp.2023.115861_b0140","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/hep.28680","article-title":"Inhibition of spleen tyrosine kinase activation ameliorates inflammation, cell death, and steatosis in alcoholic liver disease","volume":"64","author":"Bukong","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.bcp.2023.115861_b0145","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.bbrc.2020.05.171","article-title":"NLRP6 exerts a protective role via NF-kB with involvement of CCL20 in a mouse model of alcoholic hepatitis","volume":"528","author":"Ji","year":"2020","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.bcp.2023.115861_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106968","article-title":"NLRP12 negatively regulates EtOH-induced liver macrophage activation via NF-\u03baB pathway and mediates hepatocyte apoptosis in alcoholic liver injury","volume":"88","author":"Zhang","year":"2020","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.bcp.2023.115861_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154299","article-title":"Metabolic liver disease in diabetes \u2013 From mechanisms to clinical trials","volume":"111","author":"Dewidar","year":"2020","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.bcp.2023.115861_b0160","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jhep.2021.11.009","article-title":"A new perspective on NAFLD: Focusing on lipid droplets","volume":"76","author":"Scorletti","year":"2022","journal-title":"Journal of Hepatology"},{"issue":"5","key":"10.1016\/j.bcp.2023.115861_b0165","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/MEG.0000000000002530","article-title":"Mechanisms of nonalcoholic fatty liver disease development in normal-weight individuals","volume":"35","author":"Muriel","year":"2023","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1016\/j.bcp.2023.115861_b0170","article-title":"The NLRP3 Inflammasome in Nonalcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and Treatment","volume":"13","author":"Yu","year":"2022","journal-title":"Frontiers in Pharmacology"},{"issue":"7","key":"10.1016\/j.bcp.2023.115861_b0175","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nature Medicine"},{"key":"10.1016\/j.bcp.2023.115861_b0180","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.3390\/ijms22136969","article-title":"Fructose and the Liver","volume":"22","author":"Muriel","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.bcp.2023.115861_b0185","doi-asserted-by":"crossref","first-page":"8962458","DOI":"10.1155\/2017\/8962458","article-title":"Deficiency of the Purinergic Receptor 2X 7 Attenuates Nonalcoholic Steatohepatitis Induced by High-Fat Diet: Possible Role of the NLRP3 Inflammasome","author":"Blasetti Fantauzzi","year":"2017","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"6","key":"10.1016\/j.bcp.2023.115861_b0190","doi-asserted-by":"crossref","first-page":"e0234038","DOI":"10.1371\/journal.pone.0234038","article-title":"Pharmacological inhibition of P2RX7 ameliorates liver injury by reducing inflammation and fibrosis","volume":"15","author":"Baeza-Raja","year":"2020","journal-title":"PLoS One1"},{"issue":"2","key":"10.1016\/j.bcp.2023.115861_b0195","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","article-title":"Lipotoxicity and the gut-liver axis in NASH pathogenesis","volume":"68","author":"Marra","year":"2018","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1016\/j.bcp.2023.115861_b0200","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41374-018-0177-6","article-title":"Impaired mitophagy triggers NLRP3 inflammasome activation during the progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis","volume":"99","author":"Zhang","year":"2019","journal-title":"Lab. Investig."},{"issue":"5","key":"10.1016\/j.bcp.2023.115861_b0205","doi-asserted-by":"crossref","first-page":"7524","DOI":"10.1002\/jcp.27513","article-title":"Repression of TXNIP\u2013NLRP3 axis restores intestinal barrier function via inhibition of myeloperoxidase activity and oxidative stress in nonalcoholic steatohepatitis","volume":"234","author":"Bai","year":"2019","journal-title":"Journal of Cellular Physiology"},{"issue":"11","key":"10.1016\/j.bcp.2023.115861_b0210","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/s41423-018-0032-0","article-title":"Increased Tim-3 expression alleviates liver injury by regulating macrophage activation in MCD-induced NASH mice","volume":"16","author":"Du","year":"2019","journal-title":"Cellular & Molecular Immunology"},{"issue":"24","key":"10.1016\/j.bcp.2023.115861_b0215","doi-asserted-by":"crossref","first-page":"12177","DOI":"10.18632\/aging.102559","article-title":"Effects of XIAP on high fat diet-induced hepatic steatosis: a mechanism involving NLRP3 inflammasome and oxidative stress","volume":"11","author":"Zilu","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bcp.2023.115861_b0220","doi-asserted-by":"crossref","unstructured":"K. Shimada, T.R. Crother, J. Karlin, J. Dagvadorj, N. Chiba, S. Chen, V. Krishnan Ramanujan, A.J. Wolf, L. Vergnes, D.M. Ojcius, A. Rentsendorj, M. Vargas, C. Guerrero, Y. Wang, K.A. Fitzgerald, D.M. Underhill, T. Town, M. Arditi, Oxidized Mitochondrial DNA Activates the NLRP3 Inflammasome during Apoptosis, Immunity. 36 (3) (2012) 401-414.","DOI":"10.1016\/j.immuni.2012.01.009"},{"issue":"7717","key":"10.1016\/j.bcp.2023.115861_b0225","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41586-018-0372-z","article-title":"New mitochondrial DNA synthesis enables NLRP3 inflammasome activation","volume":"560","author":"Zhong","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2023.115861_b0230","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cellimm.2018.08.006","article-title":"Fatty acid activates NLRP3 inflammasomes in mouse Kupffer cells through mitochondrial DNA release","volume":"332","author":"Pan","year":"2018","journal-title":"Cellular Immunology"},{"issue":"7293","key":"10.1016\/j.bcp.2023.115861_b0235","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bcp.2023.115861_b0240","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2011.06.040","article-title":"Hepatic Free Cholesterol Accumulates in Obese, Diabetic Mice and Causes Nonalcoholic Steatohepatitis","volume":"141","author":"Van Rooyen","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2023.115861_b0245","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-981-10-8684-7_3","article-title":"Pathogenesis of NASH: How Metabolic Complications of Overnutrition Favour Lipotoxicity and Proinflammatory Fatty Liver Disease","volume":"1061","author":"Farrell","year":"2018","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"2","key":"10.1016\/j.bcp.2023.115861_b0250","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1194\/jlr.M053785","article-title":"Cholesterol-lowering drugs cause dissolution of cholesterol crystals and disperse Kupffer cell crown-like structures during resolution of NASH","volume":"56","author":"Ioannou","year":"2015","journal-title":"Journal of Lipid Research"},{"issue":"5","key":"10.1016\/j.bcp.2023.115861_b0255","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","author":"Mridha","year":"2017","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1016\/j.bcp.2023.115861_b0260","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jhep.2015.11.022","article-title":"Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism","volume":"64","author":"Wan","year":"2016","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1016\/j.bcp.2023.115861_b0265","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2174\/1570161115666170621082237","article-title":"Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease?","volume":"16","author":"Paschos","year":"2018","journal-title":"Current Vascular Pharmacology"},{"issue":"10","key":"10.1016\/j.bcp.2023.115861_b0270","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1194\/jlr.M085613","article-title":"Mitochondrial dysfunction-related lipid changes occur in nonalcoholic fatty liver disease progression","volume":"59","author":"Peng","year":"2018","journal-title":"Journal of Lipid Research"},{"issue":"18","key":"10.1016\/j.bcp.2023.115861_b0275","first-page":"8158","article-title":"Cardiolipin inhibitor ameliorates the nonalcoholic steatohepatitis through suppressing NLRP3 inflammasome activation","volume":"23","author":"Liu","year":"2019","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"9","key":"10.1016\/j.bcp.2023.115861_b0280","doi-asserted-by":"crossref","first-page":"e1879","DOI":"10.1038\/cddis.2015.248","article-title":"ER stress induces NLRP3 inflammasome activation and hepatocyte death","volume":"6","author":"Lebeaupin","year":"2015","journal-title":"Cell Death & Disease"},{"issue":"2","key":"10.1016\/j.bcp.2023.115861_b0285","first-page":"1087","article-title":"2,3,5,4\u2019-tetrahydroxy-stilbene-2-O-\u03b2-D-glucoside attenuates methionine and choline-deficient diet-induced nonalcoholic fatty liver disease","volume":"16","author":"Han","year":"2018","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"6","key":"10.1016\/j.bcp.2023.115861_b0290","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1007\/s10753-017-0628-z","article-title":"NLRP3 Deletion Inhibits the Nonalcoholic Steatohepatitis Development and Inflammation in Kupffer Cells Induced by Palmitic Acid","volume":"40","author":"Cai","year":"2017","journal-title":"Inflammation"},{"issue":"2","key":"10.1016\/j.bcp.2023.115861_b0295","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.2279","article-title":"The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance","volume":"17","author":"Vandanmagsar","year":"2011","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1016\/j.bcp.2023.115861_b0300","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhep.2020.07.041","article-title":"Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis","volume":"74","author":"Gaul","year":"2021","journal-title":"Journal of Hepatology"},{"issue":"10","key":"10.1016\/j.bcp.2023.115861_b0305","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00109-014-1170-1","article-title":"NLRP3 inflammasome activation is required for fibrosis development in NAFLD","volume":"92","author":"Wree","year":"2014","journal-title":"Journal of Molecular Medicine (Berlin, Germany)"},{"issue":"7384","key":"10.1016\/j.bcp.2023.115861_b0310","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity","volume":"482","author":"Henao-Mejia","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2023.115861_b0315","doi-asserted-by":"crossref","first-page":"12200","DOI":"10.1038\/s41598-017-11744-6","article-title":"Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD","volume":"7","author":"Pierantonelli","year":"2017","journal-title":"Scientific Reports"},{"issue":"5","key":"10.1016\/j.bcp.2023.115861_b0320","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/labinvest.2012.45","article-title":"Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis","volume":"92","author":"Dixon","year":"2012","journal-title":"Laboratory Investigation"},{"issue":"3","key":"10.1016\/j.bcp.2023.115861_b0325","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1007\/s10753-020-01190-4","article-title":"Mice Deficient in the IL-1\u03b2 Activation Genes Prtn3, Elane, and Casp1 Are Protected Against the Development of Obesity-Induced NAFLD","volume":"43","author":"Mirea","year":"2020","journal-title":"Inflammation"},{"issue":"2","key":"10.1016\/j.bcp.2023.115861_b0330","doi-asserted-by":"crossref","first-page":"e56100","DOI":"10.1371\/journal.pone.0056100","article-title":"Caspase-1 as a Central Regulator of High Fat Diet-Induced Nonalcoholic Steatohepatitis","volume":"8","author":"Dixon","year":"2013","journal-title":"PLoS One1"},{"key":"10.1016\/j.bcp.2023.115861_b0335","doi-asserted-by":"crossref","unstructured":"L. Pimentel de Sant'Ana, D.J.S. Ribeiro, A.M. Ara\u00fajo Martins, F. Neves Dos Santos, R. Corr\u00eaa, R. das Neves Almeida, M. Nogueira Eberlin, C.F. Maurice, K.G. Magalh\u00e3es, Absence of the Caspases 1\/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese Mice, Front Immunol. 10 (2020) 2926.","DOI":"10.3389\/fimmu.2019.02926"},{"issue":"5","key":"10.1016\/j.bcp.2023.115861_b0340","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.14336\/AD.2019.0116","article-title":"Pyroptosis in Liver Disease: New Insights into Disease Mechanisms","volume":"10","author":"Wu","year":"2019","journal-title":"Aging and Disease"},{"issue":"4","key":"10.1016\/j.bcp.2023.115861_b0345","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jhep.2017.11.040","article-title":"Gasdermin D plays a key role as a pyroptosis executor of nonalcoholic steatohepatitis in humans and mice","volume":"68","author":"Xu","year":"2018","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1016\/j.bcp.2023.115861_b0350","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3390\/v15010214","article-title":"Recent Advances in Protective Vaccines against Hepatitis Viruses: A Narrative Review","volume":"15","author":"Elbahrawy","year":"2023","journal-title":"Viruses"},{"issue":"10","key":"10.1016\/j.bcp.2023.115861_b0355","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a031716","article-title":"Globalization and the Changing Epidemiology of Hepatitis A Virus","volume":"8","author":"Jacobsen","year":"2018","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"10.1016\/j.bcp.2023.115861_b0360","doi-asserted-by":"crossref","unstructured":"WHO. Hepatitis E vaccine: WHO position paper, May 2015 \u2013 Recommendations, Vaccine 34 (3) (2016) 304-305.","DOI":"10.1016\/j.vaccine.2015.07.056"},{"key":"10.1016\/j.bcp.2023.115861_b0365","unstructured":"WHO. Global Progress Report on HIV, Viral Hepatitis and Sexually Transmitted Infections 2021. (2021)."},{"key":"10.1016\/j.bcp.2023.115861_b0370","unstructured":"WHO. Hepatitis C (2022)."},{"key":"10.1016\/j.bcp.2023.115861_b0375","doi-asserted-by":"crossref","unstructured":"GBD 2019 Hepatitis B Collaborators, Global, regional, and national burden of hepatitis B, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019, Lancet Gastroenterol. Hepatol. 7 (9) (2022) 796-829.","DOI":"10.1016\/S2215-0366(21)00395-3"},{"issue":"9","key":"10.1016\/j.bcp.2023.115861_b0380","doi-asserted-by":"crossref","DOI":"10.1177\/03000605211036845","article-title":"The NLRP3 inflammasome mediates liver failure by activating procaspase-1 and pro-IL-1 \u03b2 and regulating downstream CD40-CD40L signaling","volume":"49","author":"Li","year":"2021","journal-title":"The Journal of International Medical Research"},{"key":"10.1016\/j.bcp.2023.115861_b0385","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.molimm.2020.01.011","article-title":"NLRP3 inflammasome and related cytokines reflect the immune status of patients with HBV-ACLF","volume":"120","author":"Jia","year":"2020","journal-title":"Molecular Immunology"},{"key":"10.1016\/j.bcp.2023.115861_b0390","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.cyto.2018.04.032","article-title":"The role of the NLRP3 inflammasome and the activation of IL-1\u03b2 in the pathogenesis of chronic viral hepatic inflammation","volume":"110","author":"Molyvdas","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.bcp.2023.115861_b0395","doi-asserted-by":"crossref","unstructured":"T-S. Chang, C-L. Chen, Y-C. Wu, J-J. Liu, Y. Che Kuo, K-F. Lee, S-Y. Lin, S-E. Lin, S-Y. T, L-M. Kuo, Y-H. Tsai, Y-H. Huang, Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma, PLoS One 11 (2) (2016) e0149897.","DOI":"10.1371\/journal.pone.0149897"},{"issue":"16","key":"10.1016\/j.bcp.2023.115861_b0400","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1111\/jcmm.17867","article-title":"Analysis of hepatocellular carcinoma associated with hepatitis B virus","volume":"27","author":"Zheng","year":"2023","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"8","key":"10.1016\/j.bcp.2023.115861_b0405","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/jmv.25490","article-title":"Hepatitis B core antigen can regulate NLRP3 inflammasome pathway in HepG2 cells","volume":"91","author":"Ding","year":"2019","journal-title":"Journal of Medical Virology"},{"issue":"1","key":"10.1016\/j.bcp.2023.115861_b0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2022.102056","article-title":"Inhibition of hepatic NLRP3 inflammasome ameliorates nonalcoholic steatohepatitis\/hepatitis B - induced hepatic injury","volume":"47","author":"Chen","year":"2023","journal-title":"Clinics and Research in Hepatology and Gastroenterology"},{"key":"10.1016\/j.bcp.2023.115861_b0415","doi-asserted-by":"crossref","first-page":"1249198","DOI":"10.3389\/fonc.2023.1249198","article-title":"Mechanism of HBx carcinogenesis interaction with non-coding RNA in hepatocellular carcinoma","volume":"13","author":"Wang","year":"2023","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/j.bcp.2023.115861_b0420","doi-asserted-by":"crossref","first-page":"1213145","DOI":"10.3389\/fmicb.2023.1213145","article-title":"The role of hepatitis B virus genome variations in HBV-related HCC: effects on host signaling pathways","volume":"14","author":"Shoraka","year":"2023","journal-title":"Frontiers in Microbiology"},{"issue":"7","key":"10.1016\/j.bcp.2023.115861_b0425","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00011-020-01351-z","article-title":"Hepatitis B virus X protein promotes liver cell pyroptosis under oxidative stress through NLRP3 inflammasome activation","volume":"69","author":"Xie","year":"2020","journal-title":"Inflammation Research"},{"key":"10.1016\/j.bcp.2023.115861_b0430","doi-asserted-by":"crossref","unstructured":"M.P. Manns, M. Buti, E. Gane, J-M. Pawlotsky, H. Razavi, N. Terrault, Z. Younossi Hepatitis C virus infection, Nat. Rev. Dis. Prim. 3 (1) (2017) 17006.","DOI":"10.1038\/nrdp.2017.6"},{"issue":"12","key":"10.1016\/j.bcp.2023.115861_b0435","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.3390\/v14122762","article-title":"Unraveling the Molecular Mechanisms Involved in HCV-Induced Carcinogenesis","volume":"14","author":"Heredia-Torres","year":"2022","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.bcp.2023.115861_b0440","doi-asserted-by":"crossref","first-page":"170","DOI":"10.15403\/jgld-4726","article-title":"Activated Hepatic Stellate Cells (Ito Cells) - Marker of Advanced Fibrosis in Chronic Viral Hepatitis C: A Pilot Study","volume":"32","author":"Sufletel","year":"2023","journal-title":"Journal of Gastrointestinal and Liver Diseases"},{"issue":"4","key":"10.1016\/j.bcp.2023.115861_b0445","doi-asserted-by":"crossref","first-page":"e1003330","DOI":"10.1371\/journal.ppat.1003330","article-title":"IL-1\u03b2 production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease","volume":"9","author":"Negash","year":"2013","journal-title":"PLoS Pathogens"},{"issue":"1","key":"10.1016\/j.bcp.2023.115861_b0450","doi-asserted-by":"crossref","first-page":"19528","DOI":"10.1038\/s41598-022-22022-5","article-title":"Significance of elevated serum and hepatic NOD-like receptor pyrin domain containing 3 (NLRP3) in hepatitis C virus-related liver disease","volume":"12","author":"El Aggan","year":"2022","journal-title":"Scientific Reports"},{"key":"10.1016\/j.bcp.2023.115861_b0455","first-page":"1","article-title":"The Role of Autophagy and NLRP3 Inflammasome in Liver Fibrosis","author":"Tao","year":"2020","journal-title":"Biomed Research International"},{"issue":"13","key":"10.1016\/j.bcp.2023.115861_b0460","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/hepr.12883","article-title":"Hepatic nucleotide binding oligomerization domain - like receptors pyrin domain-containing 3 inflammasomes are associated with the histologic severity of nonalcoholic fatty liver disease","volume":"47","author":"Mitsuyoshi","year":"2017","journal-title":"Hepatology Research"},{"issue":"2","key":"10.1016\/j.bcp.2023.115861_b0465","doi-asserted-by":"crossref","first-page":"e1007593","DOI":"10.1371\/journal.ppat.1007593","article-title":"Modulation of calcium signaling pathway by hepatitis C virus core protein stimulates NLRP3 inflammasome activation","volume":"15","author":"Negash","year":"2019","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.bcp.2023.115861_b0470","series-title":"Hepatic Fibrosis: Mechanisms and Targets","author":"Muriel","year":"2022"},{"key":"10.1016\/j.bcp.2023.115861_b0475","doi-asserted-by":"crossref","unstructured":"S. Crespo Yanguas, B. Cogliati, J. Willebrords, M. Maes, I. Colle, B. van den Bossche, C. Pinto Marques Souza de Oliveira, W. Andraus, V.A. Ferreira Alves, I. Leclercq, M. Vinken, Experimental models of liver fibrosis, Arch. Toxicol. 90 (5) (2016) 1025-1048.","DOI":"10.1007\/s00204-015-1543-4"},{"issue":"3","key":"10.1016\/j.bcp.2023.115861_b0480","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/hep.26592","article-title":"NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice","volume":"59","author":"Wree","year":"2014","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.bcp.2023.115861_b0485","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/apm.12155","article-title":"Mechanism of interleukin-1\u03b2-induced proliferation in rat hepatic stellate cells from different levels of signal transduction","volume":"122","author":"Yaping","year":"2014","journal-title":"APMIS"},{"issue":"8","key":"10.1016\/j.bcp.2023.115861_b0490","doi-asserted-by":"crossref","first-page":"401","DOI":"10.4254\/wjh.v8.i8.401","article-title":"Role of interleukin-1 and its antagonism of hepatic stellate cell proliferation and liver fibrosis in the Abcb4(-\/-) mouse model","volume":"8","author":"Reiter","year":"2016","journal-title":"World Journal of Hepatology"},{"issue":"7","key":"10.1016\/j.bcp.2023.115861_b0495","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1478-3231.2008.01775.x","article-title":"Contribution of hepatic stellate cells and matrix metalloproteinase 9 in acute liver failure","volume":"28","author":"Yan","year":"2008","journal-title":"Liver International"},{"issue":"6","key":"10.1016\/j.bcp.2023.115861_b0500","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.3892\/mmr.2013.1719","article-title":"Interleukin-1\u03b2 upregulates matrix metalloproteinase-13 gene expression via c-Jun N-terminal kinase and p38 MAPK pathways in rat hepatic stellate cells","volume":"8","author":"Tang","year":"2013","journal-title":"Molecular Medicine Reports"},{"issue":"1","key":"10.1016\/j.bcp.2023.115861_b0505","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2010.03.052","article-title":"Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice","volume":"139","author":"Miura","year":"2010","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.bcp.2023.115861_b0510","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jhep.2011.01.048","article-title":"Lack of interleukin-1\u03b1 or interleukin-1\u03b2 inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice","volume":"55","author":"Kamari","year":"2011","journal-title":"Journal of Hepatology"},{"issue":"11","key":"10.1016\/j.bcp.2023.115861_b0515","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/labinvest.2008.91","article-title":"Activation of hepatic stellate cells is associated with cytokine expression in thioacetamide-induced hepatic fibrosis in mice","volume":"88","author":"Salguero Palacios","year":"2008","journal-title":"Lab. Investig."},{"issue":"6","key":"10.1016\/j.bcp.2023.115861_b0520","first-page":"G1324","article-title":"Interleukin-1 participates in the progression from liver injury to fibrosis","volume":"296","author":"Gieling","year":"2009","journal-title":"Am. J. Physiol. Liver Physiol."},{"issue":"8","key":"10.1016\/j.bcp.2023.115861_b0525","doi-asserted-by":"crossref","first-page":"7002","DOI":"10.1074\/jbc.M412220200","article-title":"Deficiency of Interleukin-1 Receptor Antagonist Deteriorates Fatty Liver and Cholesterol Metabolism in Hypercholesterolemic Mice","volume":"280","author":"Isoda","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/j.bcp.2023.115861_b0530","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/hep.26081","article-title":"Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice","volume":"57","author":"Miura","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2023.115861_b0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2022.109204","article-title":"Attenuation of hepatic fibrosis by p-Coumaric acid via modulation of NLRP3 inflammasome activation in C57BL\/6 mice","volume":"112","author":"Truong","year":"2023","journal-title":"The Journal of Nutritional Biochemistry"},{"issue":"14","key":"10.1016\/j.bcp.2023.115861_b0540","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1089\/ars.2015.6498","article-title":"Angiotensin-(1\u20137) Improves Liver Fibrosis by Regulating the NLRP3 Inflammasome via Redox Balance Modulation","volume":"24","author":"Cai","year":"2016","journal-title":"Antioxidants & Redox Signaling"},{"key":"10.1016\/j.bcp.2023.115861_b0545","first-page":"1273A","article-title":"Serum marker of inflammasome activity correlates with liver injury in nonalcoholic fatty liver disease and is influenced by genetic polymorphisms","volume":"62","author":"Adams","year":"2015","journal-title":"Hepatology"},{"issue":"13","key":"10.1016\/j.bcp.2023.115861_b0550","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.3390\/cancers14133150","article-title":"The Role of the NLRP3 Inflammasome in HCC Carcinogenesis and Treatment: Harnessing Innate Immunity","volume":"14","author":"Papadakos","year":"2022","journal-title":"Cancers (basel)"},{"issue":"1","key":"10.1016\/j.bcp.2023.115861_b0555","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/cancers14010226","article-title":"Tumor-Associated Macrophages in Hepatocellular Carcinoma Pathogenesis, Prognosis and Therapy","volume":"14","author":"Arvanitakis","year":"2022","journal-title":"Cancers (basel)"},{"issue":"2","key":"10.1016\/j.bcp.2023.115861_b0560","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.cell.2020.11.041","article-title":"Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma","volume":"184","author":"Sun","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2023.115861_b0565","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1007\/s43440-020-00064-8","article-title":"Alpinumisoflavone suppresses hepatocellular carcinoma cell growth and metastasis via NLRP3 inflammasome-mediated pyroptosis","volume":"72","author":"Zhang","year":"2020","journal-title":"Pharmacological Reports"},{"key":"10.1016\/j.bcp.2023.115861_b0570","doi-asserted-by":"crossref","first-page":"1150325","DOI":"10.3389\/fphar.2023.1150325","article-title":"The role of NLRP3 inflammasome in hepatocellular carcinoma","volume":"14","author":"Zhao","year":"2023","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.bcp.2023.115861_b0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110107","article-title":"Role of NLRP3 inflammasome in hepatocellular carcinoma: A double-edged sword","volume":"118","author":"Tang","year":"2023","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.bcp.2023.115861_b0580","doi-asserted-by":"crossref","unstructured":"B. Dai, H. Cao, Y. Hu, Z. Gong, X. Huang, Y. Chen, F. Liu, X. Peng, Y. Zhang, X. Lei X, Role of NLRP3 inflammasome activation in HCC cell progression, Heliyon. 26 (9) (2023) e19542.","DOI":"10.1016\/j.heliyon.2023.e19542"},{"key":"10.1016\/j.bcp.2023.115861_b0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108512","article-title":"NLRP3 promotes immune escape by regulating immune checkpoints: A pan-cancer analysis","volume":"104","author":"Ding","year":"2022","journal-title":"International Immunopharmacology"},{"issue":"17","key":"10.1016\/j.bcp.2023.115861_b0590","doi-asserted-by":"crossref","first-page":"9285","DOI":"10.3390\/ijms22179285","article-title":"NLRP3 Deficiency in Hepatocellular Carcinoma Enhances Surveillance of NK-92 through a Modulation of MICA\/B","volume":"22","author":"Lee","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.bcp.2023.115861_b0595","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bbrc.2017.08.148","article-title":"Irisin stimulates cell proliferation and invasion by targeting the PI3K\/AKT pathway in human hepatocellular carcinoma","volume":"493","author":"Shi","year":"2017","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.bcp.2023.115861_b0600","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bbrc.2021.10.041","article-title":"FNDC5 induces M2 macrophage polarization and promotes hepatocellular carcinoma cell growth by affecting the PPAR\u03b3\/NF-\u03baB\/NLRP3 pathway","volume":"582","author":"Liu","year":"2021","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"5","key":"10.1016\/j.bcp.2023.115861_b0605","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1002\/hep.29681","article-title":"Hypoxia-inducible factor-1\u03b1\/interleukin-1\u03b2 signaling enhances hepatoma epithelial\u2013mesenchymal transition through macrophages in a hypoxic-inflammatory microenvironment","volume":"67","author":"Zhang","year":"2018","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.bcp.2023.115861_b0610","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1158\/2326-6066.CIR-19-0261","article-title":"RIPK3 Orchestrates Fatty Acid Metabolism in Tumor-Associated Macrophages and Hepatocarcinogenesis","volume":"8","author":"Wu","year":"2020","journal-title":"Cancer Immunology Research"},{"issue":"6","key":"10.1016\/j.bcp.2023.115861_b0615","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1002\/jcp.30169","article-title":"Lactate and TGF-\u03b2 antagonistically regulate inflammasome activation in the tumor microenvironment","volume":"236","author":"Tu","year":"2021","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.bcp.2023.115861_b0620","article-title":"Inhibition of NEK7 Suppressed Hepatocellular Carcinoma Progression by Mediating Cancer Cell Pyroptosis, Front","volume":"12","author":"Yan","year":"2022","journal-title":"Oncol."},{"key":"10.1016\/j.bcp.2023.115861_b0625","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL Clinical Practice Guidelines: Autoimmune hepatitis","volume":"63","author":"European Association for the Study of the Liver","year":"2015","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.bcp.2023.115861_b0630","doi-asserted-by":"crossref","DOI":"10.1007\/s10238-023-01128-8","article-title":"Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives","author":"Villani","year":"2023","journal-title":"Clinical and Experimental Medicine"},{"issue":"14","key":"10.1016\/j.bcp.2023.115861_b0635","doi-asserted-by":"crossref","first-page":"1204231","DOI":"10.3389\/fimmu.2023.1204231","article-title":"T memory stem cell characteristics in autoimmune diseases and their promising therapeutic values","volume":"11","author":"Fazeli","year":"2023","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.bcp.2023.115861_b0640","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3389\/fimmu.2018.00758","article-title":"NOD-Like Receptor Protein 3 Inflammasome-Dependent IL-1\u03b2 Accelerated ConA-Induced Hepatitis","volume":"9","author":"Luan","year":"2018","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.bcp.2023.115861_b0645","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.freeradbiomed.2019.08.014","article-title":"Redox regulation of hepatic NLRP3 inflammasome activation and immune dysregulation in trichloroethene-mediated autoimmunity","volume":"143","author":"Wang","year":"2019","journal-title":"Free Radical Biology & Medicine"},{"issue":"12","key":"10.1016\/j.bcp.2023.115861_b0650","doi-asserted-by":"crossref","first-page":"e0210200","DOI":"10.1371\/journal.pone.0210200","article-title":"Trichloroethene metabolite dichloroacetyl chloride induces apoptosis and compromises phagocytosis in Kupffer Cells: Activation of inflammasome and MAPKs","volume":"13","author":"Wang","year":"2018","journal-title":"PLoS One1"},{"issue":"1","key":"10.1016\/j.bcp.2023.115861_b0655","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis","volume":"67","author":"European Association for the Study of the Liver","year":"2017","journal-title":"Journal of Hepatology"},{"issue":"9","key":"10.1016\/j.bcp.2023.115861_b0660","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.autrev.2017.07.002","article-title":"Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases","volume":"16","author":"Li","year":"2017","journal-title":"Autoimmunity Reviews"},{"issue":"4","key":"10.1016\/j.bcp.2023.115861_b0665","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.immuni.2016.09.008","article-title":"Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome","volume":"45","author":"Guo","year":"2016","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.bcp.2023.115861_b0670","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.cmet.2017.03.007","article-title":"Farnesoid X Receptor Regulation of the NLRP3 Inflammasome Underlies Cholestasis-Associated Sepsis","volume":"25","author":"Hao","year":"2017","journal-title":"Cell Metabolism"},{"issue":"12","key":"10.1016\/j.bcp.2023.115861_b0675","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1096\/fj.201600392RR","article-title":"Galectin-3 regulates inflammasome activation in cholestatic liver injury","volume":"30","author":"Tian","year":"2016","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.bcp.2023.115861_b0680","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3389\/fimmu.2019.01309","article-title":"Gal-3 Deficiency Suppresses Novosphyngobium aromaticivorans Inflammasome Activation and IL-17 Driven Autoimmune Cholangitis in Mice","volume":"10","author":"Arsenijevic","year":"2019","journal-title":"Frontiers in Immunology"},{"issue":"06","key":"10.1016\/j.bcp.2023.115861_b0685","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1055\/s-0043-107029","article-title":"Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline","volume":"49","author":"Aabakken","year":"2017","journal-title":"Endoscopy"},{"issue":"8","key":"10.1016\/j.bcp.2023.115861_b0690","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1136\/gutjnl-2018-317993","article-title":"British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis","volume":"68","author":"Chapman","year":"2019","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.bcp.2023.115861_b0695","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.3724\/abbs.2022137","article-title":"NLRP3 inflammasome activation mechanism and its role in autoimmune liver disease","volume":"54","author":"Guan","year":"2022","journal-title":"Acta Biochimica et Biophysica Sinica (Shanghai)"},{"issue":"2","key":"10.1016\/j.bcp.2023.115861_b0700","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ajpath.2016.10.010","article-title":"Nlrp3 Activation Induces Il-18 Synthesis and Affects the Epithelial Barrier Function in Reactive Cholangiocytes","volume":"187","author":"Maroni","year":"2017","journal-title":"The American Journal of Pathology"},{"issue":"8","key":"10.1016\/j.bcp.2023.115861_b0705","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1136\/gutjnl-2018-316670","article-title":"Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis","volume":"68","author":"Liao","year":"2019","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.bcp.2023.115861_b0710","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/gutjnl-2019-318487","article-title":"Microbiota as a cornerstone in the development of primary sclerosing cholangitis: paving the path for translational diagnostic and therapeutic approaches","volume":"68","author":"Mooser","year":"2019","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.bcp.2023.115861_b0715","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis \u2013 a comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.bcp.2023.115861_b0720","series-title":"Liver Pathophysiology Therapies and Antioxidants","first-page":"87","article-title":"Chapter 5. Pathogenesis of Idiosyncratic Drug Induced Liver Injury","author":"Dara","year":"2017"},{"issue":"3","key":"10.1016\/j.bcp.2023.115861_b0725","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1586\/17512433.2014.904744","article-title":"A perspective on the epidemiology of acetaminophen exposure and toxicity in the United States","volume":"7","author":"Blieden","year":"2014","journal-title":"Expert Review of Clinical Pharmacology"},{"issue":"5","key":"10.1016\/j.bcp.2023.115861_b0730","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/17425255.2023.2223959","article-title":"Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures, and estimates of burden of disease","volume":"9","author":"Chidiac","year":"2023","journal-title":"Expert Opinion on Drug Metabolism & Toxicology"},{"issue":"5","key":"10.1016\/j.bcp.2023.115861_b0735","first-page":"1239","article-title":"Epidemiology and Management of Drug-induced Liver Injury: Importance of the Updated RUCAM","volume":"11","author":"Kobayashi","year":"2023","journal-title":"Journal of Clinical and Translational Hepatology"},{"issue":"2","key":"10.1016\/j.bcp.2023.115861_b0740","first-page":"305","article-title":"Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome","volume":"119","author":"Imaeda","year":"2009","journal-title":"The Journal of Clinical Investigation"},{"issue":"3","key":"10.1016\/j.bcp.2023.115861_b0745","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.taap.2011.03.001","article-title":"Role of the Nalp3 inflammasome in acetaminophen-induced sterile inflammation and liver injury","volume":"252","author":"Williams","year":"2011","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.bcp.2023.115861_b0750","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.freeradbiomed.2020.05.012","article-title":"Baicalin promotes liver regeneration after acetaminophen-induced liver injury by inducing NLRP3 inflammasome activation","volume":"160","author":"Shi","year":"2020","journal-title":"Free Radical Biology & Medicine"},{"issue":"11","key":"10.1016\/j.bcp.2023.115861_b0755","doi-asserted-by":"crossref","first-page":"e0166856","DOI":"10.1371\/journal.pone.0166856","article-title":"Baicalin Attenuates IL-17-Mediated Acetaminophen-Induced Liver Injury in a Mouse Model","volume":"11","author":"Liao","year":"2016","journal-title":"PLoS One1"},{"issue":"01","key":"10.1016\/j.bcp.2023.115861_b0760","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1142\/S0192415X17500082","article-title":"ERK Signaling Pathway Plays a Key Role in Baicalin Protection Against Acetaminophen-Induced Liver Injury","volume":"45","author":"Liao","year":"2017","journal-title":"The American Journal of Chinese Medicine"},{"key":"10.1016\/j.bcp.2023.115861_b0765","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bcp.2018.01.026","article-title":"Baicalein and baicalin alleviate acetaminophen-induced liver injury by activating Nrf2 antioxidative pathway: The involvement of ERK1\/2 and PKC","volume":"150","author":"Shi","year":"2018","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.bcp.2023.115861_b0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2023.114590","article-title":"Acetaminophen-induced hepatotoxicity predominantly via inhibiting Nrf2 antioxidative pathway and activating TLR4-NF-\u03baB-MAPK inflammatory response in mice","volume":"252","author":"Shen","year":"2023","journal-title":"Ecotoxicology and Environmental Safety"},{"issue":"23","key":"10.1016\/j.bcp.2023.115861_b0775","doi-asserted-by":"crossref","first-page":"e33889","DOI":"10.1097\/MD.0000000000033889","article-title":"Relapsing autoimmune inner ear disease with significant response to methotrexate and azathioprine combination therapy: A case report and mini literature review","volume":"102","author":"Huang","year":"2023","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"10.1016\/j.bcp.2023.115861_b0780","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1542-3565(04)00344-1","article-title":"Azathioprine, 6-mercaptopurine in inflammatory bowel disease: Pharmacology, efficacy, and safety","volume":"2","author":"Dubinsky","year":"2004","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.bcp.2023.115861_b0785","first-page":"6726384","article-title":"Increased Risk of Liver Cirrhosis during Azathioprine Therapy for Crohn's Disease","volume":"28","author":"Roselli","year":"2020","journal-title":"Case Reports in Gastrointestinal Medicine"},{"issue":"7","key":"10.1016\/j.bcp.2023.115861_b0790","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1440-1746.2009.05917.x","article-title":"Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyltransferase genotype in Japanese patients with inflammatory bowel disease","volume":"24","author":"Takatsu","year":"2009","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"2","key":"10.1016\/j.bcp.2023.115861_b0795","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.toxlet.2013.10.025","article-title":"Involvement of oxidative stress and immune- and inflammation-related factors in azathioprine-induced liver injury","volume":"224","author":"Matsuo","year":"2014","journal-title":"Toxicology Letters"},{"key":"10.1016\/j.bcp.2023.115861_b0800","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.fitote.2013.06.016","article-title":"Psoralea corylifolia L. (Buguchi) \u2014 Folklore to modern evidence: Review","volume":"90","author":"Chopra","year":"2013","journal-title":"Fitoterapia"},{"key":"10.1016\/j.bcp.2023.115861_b0805","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jep.2019.01.006","article-title":"Systematic review of published data on herb induced liver injury","volume":"233","author":"Byeon","year":"2019","journal-title":"Journal of Ethnopharmacology"},{"issue":"3","key":"10.1016\/j.bcp.2023.115861_b0810","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/liv.14306","article-title":"Clinicopathological features of Bu Gu Zhi-induced liver injury, a long-term follow-up cohort study","volume":"40","author":"Wang","year":"2020","journal-title":"Liver International"},{"issue":"2","key":"10.1016\/j.bcp.2023.115861_b0815","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jphs.2020.11.012","article-title":"Sestrin2 protects against bavachin induced ER stress through AMPK\/mTORC1 signaling pathway in HepG2 cells","volume":"145","author":"Yang","year":"2021","journal-title":"Journal of Pharmacological Sciences"},{"issue":"4","key":"10.1016\/j.bcp.2023.115861_b0820","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s11684-020-0809-2","article-title":"Bavachin enhances NLRP3 inflammasome activation induced by ATP or nigericin and causes idiosyncratic hepatotoxicity","volume":"15","author":"Qin","year":"2021","journal-title":"Frontiers in Medicine"},{"issue":"11","key":"10.1016\/j.bcp.2023.115861_b0825","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1128\/MCB.01152-07","article-title":"RelA Ser 276 Phosphorylation Is Required for Activation of a Subset of NF-\u03baB-Dependent Genes by Recruiting Cyclin-Dependent Kinase 9\/Cyclin T1 Complexes","volume":"28","author":"Nowak","year":"2008","journal-title":"Molecular Cell. Biology"},{"issue":"2","key":"10.1016\/j.bcp.2023.115861_b0830","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ni.1831","article-title":"Thioredoxin-interacting protein links oxidative stress to inflammasome activation","volume":"11","author":"Zhou","year":"2010","journal-title":"Nature Immunology"},{"issue":"7","key":"10.1016\/j.bcp.2023.115861_b0835","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41590-020-0669-6","article-title":"FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation","volume":"21","author":"Jacob Hu","year":"2020","journal-title":"Nature Immunology"},{"issue":"1","key":"10.1016\/j.bcp.2023.115861_b0840","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/jat.3880","article-title":"Free radicals, antioxidants, nuclear factor-E2-related factor-2 and liver damage","volume":"40","author":"Ramos-Tovar","year":"2020","journal-title":"Journal of Applied Toxicology"},{"key":"10.1016\/j.bcp.2023.115861_b0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2020.108573","article-title":"Sulforaphane ameliorates ethanol plus carbon tetrachloride-induced liver fibrosis in mice through the Nrf2-mediated antioxidant response and acetaldehyde metabolization with inhibition of the LPS\/TLR4 signaling pathway","volume":"89","author":"Ishida","year":"2021","journal-title":"The Journal of Nutritional Biochemistry"},{"issue":"10","key":"10.1016\/j.bcp.2023.115861_b0850","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3390\/antiox9100980","article-title":"Roles of Nrf2 in Liver Diseases: Molecular, Pharmacological, and Epigenetic Aspects","volume":"9","author":"Galicia-Moreno","year":"2020","journal-title":"Antioxidants"},{"issue":"6","key":"10.1016\/j.bcp.2023.115861_b0855","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.3390\/cells9061342","article-title":"Reactive Oxygen Species and Redox Signaling in Chronic Kidney Disease","volume":"9","author":"Irazabal","year":"2020","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.bcp.2023.115861_b0860","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jhep.2020.09.037","article-title":"Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis","volume":"74","author":"Mohs","year":"2021","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.bcp.2023.115861_b0865","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.3389\/fimmu.2019.02538","article-title":"Pharmacological Inhibitors of the NLRP3 Inflammasome","volume":"10","author":"Zahid","year":"2019","journal-title":"Frontiers in Immunology"},{"issue":"3","key":"10.1016\/j.bcp.2023.115861_b0870","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3390\/nu14030490","article-title":"Modulatory Properties of Food and Nutraceutical Components Targeting NLRP3 Inflammasome Activation","volume":"14","author":"Spano","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.bcp.2023.115861_b0875","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.abb.2019.01.031","article-title":"The NLRP3 inflammasome - interleukin 1 pathway as a therapeutic target in gout","volume":"670","author":"Szekanecz","year":"2019","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10.1016\/j.bcp.2023.115861_b0880","first-page":"e325","article-title":"Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study, Lancet","volume":"2","author":"Cavalli","year":"2020","journal-title":"Rheumatol."},{"key":"10.1016\/j.bcp.2023.115861_b0885","first-page":"e457-ee458","article-title":"Canakinumab in a subgroup of patients with COVID-19, Lancet","volume":"2","author":"Ucciferri","year":"2020","journal-title":"Rheumatol."},{"key":"10.1016\/j.bcp.2023.115861_b0890","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ejphar.2019.03.031","article-title":"rhIL-1Ra reduces hepatocellular apoptosis in mice with acute liver failure mainly by inhibiting the activities of Kupffer cells","volume":"854","author":"Yu","year":"2019","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.bcp.2023.115861_b0895","series-title":"Dimethyl fumarate-mediated Nrf2\/ARE pathway activation and glibenclamide-mediated NLRP3 inflammasome cascade inhibition alleviate type II diabetes-associated fatty liver in rats by mitigating oxidative stress and inflammation","author":"Dwivedi","year":"2023"},{"key":"10.1016\/j.bcp.2023.115861_b0900","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nature Medicine"},{"key":"10.1016\/j.bcp.2023.115861_b0905","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrd.2018.97","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/j.bcp.2023.115861_b0910","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abe2933","article-title":"Pharmacological targeting of NLRP3 deubiquitination for treatment of NLRP3-associated inflammatory diseases","volume":"6","author":"Ren","year":"2021","journal-title":"Science Immunology"},{"key":"10.1016\/j.bcp.2023.115861_b0915","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/hep.29569","article-title":"A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis","volume":"67","author":"Kowdley","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2023.115861_b0920","doi-asserted-by":"crossref","first-page":"15020","DOI":"10.1038\/s41598-017-15314-8","article-title":"BOT-4-one attenuates NLRP3 inflammasome activation: NLRP3 alkylation leading to the regulation of its ATPase activity and ubiquitination","volume":"7","author":"Shim","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.bcp.2023.115861_b0925","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12974-017-0985-4","article-title":"Antidiabetic drug glyburide modulates depressive-like behavior comorbid with insulin resistance","volume":"14","author":"Su","year":"2017","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.bcp.2023.115861_b0930","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1083\/jcb.200903124","article-title":"Glyburide inhibits the Cryopyrin\/Nalp3 inflammasome","volume":"187","author":"Lamkanfi","year":"2009","journal-title":"The Journal of Cell Biology"},{"key":"10.1016\/j.bcp.2023.115861_b0935","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101843","article-title":"Upregulated NLRP3 inflammasome activation is attenuated by anthocyanins in patients with nonalcoholic fatty liver disease: A case-control and an intervention study","volume":"46","author":"Zhu","year":"2022","journal-title":"Clinics and Research in Hepatology and Gastroenterology"},{"key":"10.1016\/j.bcp.2023.115861_b0940","doi-asserted-by":"crossref","first-page":"e0134172","DOI":"10.1371\/journal.pone.0134172","article-title":"Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease","volume":"10","author":"Yan","year":"2015","journal-title":"PLoS One1"},{"key":"10.1016\/j.bcp.2023.115861_b0945","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/3593951","article-title":"The Therapeutic Effect of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis","volume":"2016","author":"Wei","year":"2016","journal-title":"Evidence-Based Complement. Altern. Med."},{"key":"10.1016\/j.bcp.2023.115861_b0950","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1089\/jmf.2013.0179","article-title":"Silymarin inhibits the progression of fibrosis in the early stages of liver injury in CCl\u2084-treated rats","volume":"18","author":"Clichici","year":"2015","journal-title":"Journal of Medicinal Food"},{"key":"10.1016\/j.bcp.2023.115861_b0955","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1111\/j.1572-0241.2001.04129.x","article-title":"Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study","volume":"96","author":"Abdelmalek","year":"2001","journal-title":"The American Journal of Gastroenterology"},{"key":"10.1016\/j.bcp.2023.115861_b0960","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14852","article-title":"Javad Hosseinzadeh-Attar, Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight\/obese patients with NAFLD? A randomised, double-blind, placebo-controlled, clinical trial","volume":"75","author":"Namkhah","year":"2021","journal-title":"International Journal of Clinical Practice"},{"key":"10.1016\/j.bcp.2023.115861_b0965","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MEG.0000000000002323","article-title":"Effects of naringenin supplementation on cardiovascular risk factors in overweight\/obese patients with nonalcoholic fatty liver disease: a pilot double-blind, placebo-controlled, randomized clinical trial","volume":"34","author":"Naeini","year":"2022","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1016\/j.bcp.2023.115861_b0970","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1295494","article-title":"Naringenin protects against acute pancreatitis-associated intestinal injury by inhibiting NLRP3 inflammasome activation via AhR signaling","volume":"14","author":"Yan","year":"2023","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.bcp.2023.115861_b0975","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/hep.23239","article-title":"Betaine for nonalcoholic fatty liver disease: Results of a randomized placebo-controlled trial","volume":"50","author":"Abdelmalek","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2023.115861_b0980","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41430-020-0679-3","article-title":"The efficacy of flaxseed and hesperidin on non-alcoholic fatty liver disease: an open-labeled randomized controlled trial","volume":"75","author":"Yari","year":"2021","journal-title":"European Journal of Clinical Nutrition"},{"key":"10.1016\/j.bcp.2023.115861_b0985","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166620","article-title":"Hesperidin methyl chalcone ameliorates lipid metabolic disorders by activating lipase activity and increasing energy metabolism","volume":"1869","author":"Liu","year":"2023","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"key":"10.1016\/j.bcp.2023.115861_b0990","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2022.112823","article-title":"Curcumin mitigates aflatoxin B1-induced liver injury via regulating the NLRP3 inflammasome and Nrf2 signaling pathway","volume":"161","author":"Wang","year":"2022","journal-title":"Food and Chemical Toxicology"},{"key":"10.1016\/j.bcp.2023.115861_b0995","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1024\/0300-9831\/a000629","article-title":"Efficacy of phytosomal curcumin among patients with non-alcoholic fatty liver disease","volume":"91","author":"Mirhafez","year":"2021","journal-title":"International Journal for Vitamin and Nutrition Research"},{"key":"10.1016\/j.bcp.2023.115861_b1000","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/ptr.5659","article-title":"Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial","volume":"30","author":"Rahmani","year":"2016","journal-title":"Phyther. Res."},{"key":"10.1016\/j.bcp.2023.115861_b1005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175504","article-title":"Asperuloside alleviates lipid accumulation and inflammation in HFD-induced NAFLD via AMPK signaling pathway and NLRP3 inflammasome","volume":"942","author":"Shen","year":"2023","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.bcp.2023.115861_b1010","doi-asserted-by":"crossref","unstructured":"W. Shi, G. Xu, X. Zhan, Y. Gao, Z. Wang, S. Fu, N. Qin, X. Hou, Y. Ai, C. Wang, T. He, H. Liu, Y. Chen, Y. Liu, J. Wang, M. Niu, Y. Guo, X. Xiao, Z. Bai, Carnosol inhibits inflammasome activation by directly targeting HSP90 to treat inflammasome-mediated diseases. Cell Death Dis. 11(4) (2020252).","DOI":"10.1038\/s41419-020-2460-x"},{"issue":"7","key":"10.1016\/j.bcp.2023.115861_b1015","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1517\/13543784.2012.690032","article-title":"Current status of inflammasome blockers as anti-inflammatory drugs","volume":"21","author":"L\u00f3pez-Castej\u00f3n","year":"2012","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.1016\/j.bcp.2023.115861_b1020","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1172\/JCI60777","article-title":"IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice","volume":"122","author":"Petrasek","year":"2012","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.bcp.2023.115861_b1025","first-page":"401","article-title":"Role of interleukin-1 and its antagonism of hepatic stellate cell proliferation and liver fibrosis in the Abcb4 -\/- mouse model, World","volume":"8","author":"Reiter","year":"2016","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.bcp.2023.115861_b1030","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/hep.26592","article-title":"NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice","volume":"59","author":"Wree","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2023.115861_b1035","doi-asserted-by":"crossref","first-page":"e89961","DOI":"10.1371\/journal.pone.0089961","article-title":"Luteoloside suppresses proliferation and metastasis of hepatocellular carcinoma cells by inhibition of NLRP3 inflammasome","volume":"9","author":"Fan","year":"2014","journal-title":"PLoS One1"},{"key":"10.1016\/j.bcp.2023.115861_b1040","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00210-019-01773-5","article-title":"NLRP3 inhibitor glibenclamide attenuates high-fat diet and streptozotocin-induced non-alcoholic fatty liver disease in rat: studies on oxidative stress, inflammation, DNA damage and insulin signalling pathway, Naunyn. Schmiedebergs","volume":"393","author":"Dwivedi","year":"2020","journal-title":"Archives of Pharmacology"},{"key":"10.1016\/j.bcp.2023.115861_b1045","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.bbrc.2020.11.009","article-title":"NLRP3 inflammasome inhibitor CY-09 reduces hepatic steatosis in experimental NAFLD mice","volume":"534","author":"Wang","year":"2021","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.bcp.2023.115861_b1050","doi-asserted-by":"crossref","first-page":"7611","DOI":"10.4049\/jimmunol.175.11.7611","article-title":"Potentiation of Caspase-1 Activation by the P2X7 Receptor Is Dependent on TLR Signals and Requires NF-\u03baB-Driven Protein Synthesis","volume":"175","author":"Kahlenberg","year":"2005","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.bcp.2023.115861_b1055","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4049\/jimmunol.0901363","article-title":"Cutting Edge: NF-\u03baB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression","volume":"183","author":"Bauernfeind","year":"2009","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.bcp.2023.115861_b1060","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3390\/biom11020162","article-title":"Anti-Inflammatory Effects of Rosmarinic Acid-Loaded Nanovesicles in Acute Colitis through Modulation of NLRP3 Inflammasome","volume":"11","author":"Marinho","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.bcp.2023.115861_b1065","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11010-014-2162-8","article-title":"Rutin modulates ASC expression in NLRP3 inflammasome: a study in alcohol and cerulein-induced rat model of pancreatitis","volume":"396","author":"Aruna","year":"2014","journal-title":"Molecular and Cellular Biochemistry"},{"key":"10.1016\/j.bcp.2023.115861_b1070","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.3390\/nu14142809","article-title":"Thymol Alleviates LPS-Induced Liver Inflammation and Apoptosis by Inhibiting NLRP3 Inflammasome Activation and the AMPK-mTOR-Autophagy Pathway","volume":"14","author":"Dou","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.bcp.2023.115861_b1075","doi-asserted-by":"crossref","first-page":"21224","DOI":"10.1002\/jcp.28728","article-title":"Cannabidiol protects livers against nonalcoholic steatohepatitis induced by high-fat high cholesterol diet via regulating NF-\u03baB and NLRP3 inflammasome pathway","volume":"234","author":"Huang","year":"2019","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.bcp.2023.115861_b1080","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/MEG.0000000000001485","article-title":"Herbal medicines for the liver","volume":"32","author":"Vargas-Pozada","year":"2020","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1016\/j.bcp.2023.115861_b1085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115762","article-title":"Nicotinic acid attenuates experimental non-alcoholic steatohepatitis by inhibiting the NLRP3 inflammasome\/pyroptosis pathway","volume":"216","author":"Cardoso-Lezama","year":"2023","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.bcp.2023.115861_b1090","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.freeradbiomed.2020.08.006","article-title":"Cyanidin-3-O-\u03b2-glucoside inactivates NLRP3 inflammasome and alleviates alcoholic steatohepatitis via SirT1\/NF-\u03baB signaling pathway","volume":"160","author":"Zhou","year":"2020","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/j.bcp.2023.115861_b1095","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.3390\/ijms23179954","article-title":"Caffeine Inhibits NLRP3 Inflammasome Activation by Downregulating TLR4\/MAPK\/NF-\u03baB Signaling Pathway in an Experimental NASH Model","volume":"23","author":"Vargas-Pozada","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.bcp.2023.115861_b1100","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2023.112567","article-title":"Effectiveness of targeting the NLRP3 inflammasome by using natural polyphenols: A systematic review of implications on health effects","volume":"165","author":"Wang","year":"2023","journal-title":"Food Research International"},{"key":"10.1016\/j.bcp.2023.115861_b1105","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1021\/acs.jafc.9b04259","article-title":"Pterostilbene Improves Hepatic Lipid Accumulation via the MiR-34a\/Sirt1\/SREBP-1 Pathway in Fructose-Fed Rats","volume":"68","author":"Wu","year":"2020","journal-title":"Journal of Agricultural and Food Chemistry"},{"issue":"9","key":"10.1016\/j.bcp.2023.115861_b1110","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41584-022-00804-5","article-title":"When underlying biology threatens the randomization principle \u2014 initial gout flares of urate-lowering therapy","volume":"18","author":"Choi","year":"2022","journal-title":"Nature Reviews Rheumatology"},{"issue":"10","key":"10.1016\/j.bcp.2023.115861_b1115","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1172\/JCI60777","article-title":"IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice","volume":"122","author":"Petrasek","year":"2012","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.bcp.2023.115861_b1120","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107765","article-title":"Interleukin-1 in obesity-related low-grade inflammation: From molecular mechanisms to therapeutic strategies","volume":"96","author":"Ghanbari","year":"2021","journal-title":"International Immunopharmacology"},{"issue":"6","key":"10.1016\/j.bcp.2023.115861_b1125","first-page":"1186","article-title":"Therapeutic Perspectives of IL1 Family Members in Liver Diseases: An Update","volume":"10","author":"\u0106ur\u010di\u0107","year":"2022","journal-title":"Journal of Clinical and Translational Hepatology"},{"issue":"8","key":"10.1016\/j.bcp.2023.115861_b1130","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1080\/15548627.2015.1058473","article-title":"Macrophage autophagy protects against liver fibrosis in mice","volume":"11","author":"Lodder","year":"2015","journal-title":"Autophagy"},{"issue":"8","key":"10.1016\/j.bcp.2023.115861_b1135","doi-asserted-by":"crossref","first-page":"401","DOI":"10.4254\/wjh.v8.i8.401","article-title":"Role of interleukin-1 and its antagonism of hepatic stellate cell proliferation and liver fibrosis in the Abcb4 -\/- mouse model","volume":"8","author":"Reiter","year":"2016","journal-title":"World Journal of Hepatology"},{"issue":"6","key":"10.1016\/j.bcp.2023.115861_b1140","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3390\/ijms20061295","article-title":"Interleukin-1 Receptor Antagonist Modulates Liver Inflammation and Fibrosis in Mice in a Model-Dependent Manner","volume":"20","author":"Meier","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.bcp.2023.115861_b1145","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3892\/mmr.2013.1807","article-title":"P2X7 blockade attenuates mouse liver fibrosis","volume":"9","author":"Huang","year":"2014","journal-title":"Molecular Medicine Reports"},{"issue":"1","key":"10.1016\/j.bcp.2023.115861_b1150","doi-asserted-by":"crossref","first-page":"15020","DOI":"10.1038\/s41598-017-15314-8","article-title":"BOT-4-one attenuates NLRP3 inflammasome activation: NLRP3 alkylation leading to the regulation of its ATPase activity and ubiquitination","volume":"7","author":"Shim","year":"2017","journal-title":"Scientific Reports"},{"issue":"19","key":"10.1016\/j.bcp.2023.115861_b1155","doi-asserted-by":"crossref","first-page":"16567","DOI":"10.1074\/jbc.M211596200","article-title":"Glutathione s-transferase omega 1\u20131 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1beta posttranslational processing","volume":"278","author":"Laliberte","year":"2003","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.bcp.2023.115861_b1160","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108867","article-title":"Dimethyl fumarate ameliorates autoimmune hepatitis in mice by blocking NLRP3 inflammasome activation","volume":"108","author":"Shi","year":"2022","journal-title":"International Immunopharmacology"},{"issue":"58","key":"10.1016\/j.bcp.2023.115861_b1165","doi-asserted-by":"crossref","first-page":"eabe2933","DOI":"10.1126\/sciimmunol.abe2933","article-title":"Pharmacological targeting of NLRP3 deubiquitination for treatment of NLRP3-associated inflammatory diseases","volume":"6","author":"Ren","year":"2021","journal-title":"Science Immunology"},{"key":"10.1016\/j.bcp.2023.115861_b1170","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.971745","article-title":"Interleukin-18 in metabolism: From mice physiology to human diseases","volume":"13","author":"Somm","year":"2022","journal-title":"Front. Endocrinol. (lausanne)."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223004525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223004525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T09:37:45Z","timestamp":1736329065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295223004525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":234,"alternative-id":["S0006295223004525"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115861","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NLRP3 inflammasome in hepatic diseases: A pharmacological target","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115861","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115861"}}